Search

Search Constraints

You searched for: Author/Creator Gaita, Dan

Search Results

1. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (November 2019)

2. Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: Physician survey and good clinical practice recommendations from an international expert panel. (February 2021)

3. Cardiac rehabilitation availability and delivery in Europe: How does it differ by region and compare with other high-income countries?: Endorsed by the European Association of Preventive Cardiology. (July 2019)

4. Cardiac rehabilitation availability and delivery in Europe: How does it differ by region and compare with other high-income countries?: Endorsed by the European Association of Preventive Cardiology. (29th August 2020)

5. Cardiac Rehabilitation Availability and Density around the Globe. (August 2019)

6. Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140–205]. (February 2020)

7. Corrigendum to "Exercise-based cardiac rehabilitation in twelve European countries: Results of the European Cardiac Rehabilitation Registry" [Int. J. Cardiol. 228 (2017) 58–67]. (1st September 2017)

8. Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era. (7th November 2020)

9. Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140–205]. (January 2020)

10. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. (28th August 2020)